Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-06-27
2006-06-27
Saunders, David (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S015000, C435S029000, C436S063000, C436S501000
Reexamination Certificate
active
07067266
ABSTRACT:
The present invention provides compositions and methods for modulating leukocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating leukocyte activation are provided. Compositions and methods for the treatment of disorders related to leukocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating leukocyte activation.
REFERENCES:
patent: 6239133 (2001-05-01), Barrish et al.
patent: 2001/0006789 (2001-07-01), Maino et al.
patent: 2002/0076733 (2002-06-01), Kasibhatla et al.
Bosco et al., “IL-2 Signaling In Human Monocytes Involves the Phosphorylation and Activation of p59hck1”,J. Immunol.164: 4575-4585 (2000).
Brown et al., “Activation of the PAK-Related Kinase by Human Immunodeficiency Virus Type 1 Nef in Primary Human Peripheral Blood Lymphocytes and Macrophages Leads to Phosphorylation of a PIX-p95 Complex”,Journal of Virology73:12: 9899-9907 (1999).
Kim et al., “Signaling Function of the B-Cell Antigen Receptors”,Immunological Reviews132: 126-145 (1993).
Reth, “Antigen Receptors on B Lymphocytes”,Annu. Rev. Immunol.10: 97-121 (1992).
Schlessinger, “Cell Signaling by Receptor Tyrosine Kinases”,Cell:103: 211-225 (2000).
Scott et al., “Identification of Novel SH3 Domain Ligards for the Src Family Kinase Hck”,The Journal of Biological Chemistry277:31: 28238-28246 (2002).
Quintrell et al., “Identification of a Human Gene (HCK) That Encodes a Protein-Tyrosine Kinase and is Expressed in Hemopoietic Cells”,Molecular and Cellular Biology7:6: 2267-2275 (1987).
Verkoczy et al., “Characterization of the Human B Cell RAG-associated Gene,hBRAG, as a B Cell Receptor Signal-enhancing Glycoprotein Dimer That Associates with Phosphorylated Proteins in Resting B Cells”,The Journal of Biological Chemistry275:28: 20967-20979 (2000>.
Ziegler et al., “Novel Protein-Tyrosine Kinase Gene (hck) Preferentially Expressed in Cells of Hematopoietic Origin”,Molecular and Cellular Biology7:6: 2276-2285 (1987).
Zilber et al., “CD38 expressed on human monocytes: A coaccessory molecule in the superantigen-induced proliferation”,PNAS97:6: 2840-2845 (2000).
Friera Annabelle
Masuda Esteban
Powell Mark
Wong Brian R.
Rigel Pharmaceuticals Inc.
Saunders David
LandOfFree
Modulators of leukocyte activation, Hck compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of leukocyte activation, Hck compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of leukocyte activation, Hck compositions and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3665268